JP2022505928A5 - - Google Patents
Info
- Publication number
- JP2022505928A5 JP2022505928A5 JP2021523014A JP2021523014A JP2022505928A5 JP 2022505928 A5 JP2022505928 A5 JP 2022505928A5 JP 2021523014 A JP2021523014 A JP 2021523014A JP 2021523014 A JP2021523014 A JP 2021523014A JP 2022505928 A5 JP2022505928 A5 JP 2022505928A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- nanoparticles
- pharmaceutically acceptable
- acceptable salt
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862748798P | 2018-10-22 | 2018-10-22 | |
| US62/748,798 | 2018-10-22 | ||
| PCT/US2019/057406 WO2020086555A1 (en) | 2018-10-22 | 2019-10-22 | Antiviral prodrugs and nanoformulations thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022505928A JP2022505928A (ja) | 2022-01-14 |
| JP2022505928A5 true JP2022505928A5 (cg-RX-API-DMAC7.html) | 2022-11-09 |
| JP7437051B2 JP7437051B2 (ja) | 2024-02-22 |
Family
ID=70331730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021523014A Active JP7437051B2 (ja) | 2018-10-22 | 2019-10-22 | 抗ウイルスプロドラッグおよびそのナノ製剤 |
Country Status (18)
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4751717A3 (en) | 2018-10-22 | 2026-08-05 | Board of Regents of the University of Nebraska | Antiviral prodrugs and nanoformulations thereof |
| CN118873676A (zh) | 2018-11-29 | 2024-11-01 | 内布拉斯加大学董事会 | 抗病毒前药及其纳米制剂 |
| KR20240151256A (ko) | 2019-03-22 | 2024-10-17 | 길리애드 사이언시즈, 인코포레이티드 | 가교된 트리시클릭 카르바모일피리돈 화합물 및 그의 제약 용도 |
| EP4110783A1 (en) | 2020-02-24 | 2023-01-04 | Gilead Sciences, Inc. | Tetracyclic compounds for treating hiv infection |
| CN116390924B (zh) | 2020-09-30 | 2025-11-07 | 吉利德科学公司 | 桥连三环氨基甲酰基吡啶酮化合物及其用途 |
| CR20260070A (es) | 2021-01-19 | 2026-04-24 | Gilead Sciences Inc | COMPUESTOS DE PIRIDOTRIAZINA SUSTITUIDOS Y USOS DE ESTOS (Divisional 2023-0315) |
| WO2023183472A1 (en) * | 2022-03-23 | 2023-09-28 | Board Of Regents Of The University Of Nebraska | Antiviral prodrugs and use thereof |
| TWI856796B (zh) | 2022-04-06 | 2024-09-21 | 美商基利科學股份有限公司 | 橋聯三環胺甲醯基吡啶酮化合物及其用途 |
| CN120936599A (zh) * | 2023-01-18 | 2025-11-11 | 歌礼生物科技(杭州)有限公司 | 整合酶抑制剂及其应用 |
| CN121194783A (zh) * | 2023-03-17 | 2025-12-23 | 依沙维治疗公司 | 抗病毒前药的制剂 |
| WO2024196661A1 (en) * | 2023-03-17 | 2024-09-26 | Exavir Therapeutics, Inc. | Crystalline forms of an antiviral prodrug |
| WO2024227037A1 (en) * | 2023-04-26 | 2024-10-31 | University Of Washington | Long-acting colloidal pharmaceutical compositions of integrase strand transfer inhibitors and related methods |
| WO2025011661A1 (zh) * | 2023-07-12 | 2025-01-16 | 歌礼生物科技(杭州)有限公司 | 整合酶抑制类的制剂及其制备方法 |
| TW202543636A (zh) | 2023-12-12 | 2025-11-16 | 美商 Viiv 醫療保健公司 | 結晶形式 |
| WO2025128498A1 (en) * | 2023-12-12 | 2025-06-19 | Viiv Healthcare Company | Pharmaceutical compositions |
| WO2026012272A1 (en) * | 2024-07-12 | 2026-01-15 | Ascletis Bioscience Co., Ltd. | Integrase inhibitor and use thereof |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3187225T3 (da) * | 2005-04-28 | 2022-02-28 | Viiv Healthcare Co | Polycyklisk carbamoylpyridonderivat med hiv-integrasehæmmende aktivitet |
| EP2660239B1 (en) * | 2008-07-25 | 2016-11-23 | VIIV Healthcare Company | Chemical compounds as synthetic intermediates |
| SMT202100268T1 (it) * | 2010-08-05 | 2021-07-12 | Shionogi & Co | Metodo per produrre composti aventi attività di inibizione di integrasi di hiv. |
| TWI577377B (zh) * | 2010-09-16 | 2017-04-11 | Viiv醫療保健公司 | 醫藥組合物 |
| LT2620436T (lt) * | 2010-09-24 | 2018-08-10 | Shionogi & Co., Ltd. | Pakeistojo policiklinio karbamoilpiridono darinio provaistas |
| JP2013542945A (ja) | 2010-11-02 | 2013-11-28 | ボード オブ リージェンツ オブ ザ ユニバーシティ オブ ネブラスカ | 治療を送達するための組成物および方法 |
| WO2014047562A2 (en) * | 2012-09-21 | 2014-03-27 | Epiphany Biosciences | Method of treating and/or preventing shingles and method of treating and/or preventing zoster associated pain |
| US10485800B2 (en) | 2012-11-30 | 2019-11-26 | The University Of Rochester | Mixed lineage kinase inhibitors for HIV/AIDS therapies |
| EA030003B1 (ru) * | 2012-12-21 | 2018-06-29 | Джилид Сайэнс, Инк. | Полициклическое карбамоилпиридоновое соединение и его фармацевтическое применение для лечения вич-инфекции |
| HK1214817A1 (en) * | 2012-12-27 | 2016-08-05 | Japan Tobacco Inc. | Substituted spiropyrido[1,2-a]pyrazine derivative and medicinal use thereof as hiv integrase inhibitor |
| US9951079B2 (en) | 2013-06-13 | 2018-04-24 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds as HIV integrase inhibitors |
| EA201690146A1 (ru) | 2013-08-14 | 2016-07-29 | Ратиофарм Гмбх | Лекарственное средство, содержащее фармацевтическую комбинацию долутегравира, эмтрицитабина и тенофовира |
| CN117164657A (zh) * | 2014-08-12 | 2023-12-05 | 莫纳什大学 | 定向淋巴的前药 |
| US10081647B2 (en) * | 2015-03-26 | 2018-09-25 | Merck Sharp & Dohme Corp. | Phosphate substituted quinolizine derivatives useful as HIV integrase inhibitors |
| EP3334722A1 (en) * | 2015-08-12 | 2018-06-20 | VIIV Healthcare UK (No.5) Limited | 5-(n-fused tricyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3- yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication |
| WO2017113288A1 (en) * | 2015-12-31 | 2017-07-06 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds as hiv integrase inhibitors |
| JP7160466B2 (ja) | 2016-06-23 | 2022-10-25 | ヴィーブ ヘルスケア カンパニー | 治療薬の送達のための組成物及び方法 |
| LT3347352T (lt) * | 2016-08-19 | 2019-08-12 | Gilead Sciences, Inc. | Terapiniai junginiai, naudotini živ viruso infekcijos profilaktikai arba terapiniam gydymui |
| AR112412A1 (es) * | 2017-08-17 | 2019-10-23 | Gilead Sciences Inc | Formas de sal de colina de un inhibidor de la cápside del vih |
| EP4751717A3 (en) | 2018-10-22 | 2026-08-05 | Board of Regents of the University of Nebraska | Antiviral prodrugs and nanoformulations thereof |
| CN118873676A (zh) | 2018-11-29 | 2024-11-01 | 内布拉斯加大学董事会 | 抗病毒前药及其纳米制剂 |
| MX2023005447A (es) | 2020-11-10 | 2023-09-25 | Unity Biotechnology Inc | Inhibidor de sales sólidas cristalinas de meglumina de bcl y métodos de elaboración y uso de estos. |
-
2019
- 2019-10-22 EP EP26157385.1A patent/EP4751717A3/en active Pending
- 2019-10-22 CA CA3117453A patent/CA3117453A1/en active Pending
- 2019-10-22 CA CA3316153A patent/CA3316153A1/en active Pending
- 2019-10-22 AU AU2019368247A patent/AU2019368247B2/en active Active
- 2019-10-22 CN CN202310352412.0A patent/CN116375735B/zh active Active
- 2019-10-22 IL IL282551A patent/IL282551B2/en unknown
- 2019-10-22 CN CN201980085100.XA patent/CN113226319B/zh active Active
- 2019-10-22 KR KR1020247026674A patent/KR102908976B1/ko active Active
- 2019-10-22 JP JP2021523014A patent/JP7437051B2/ja active Active
- 2019-10-22 MX MX2021004679A patent/MX2021004679A/es unknown
- 2019-10-22 EP EP23160610.4A patent/EP4234561B1/en active Active
- 2019-10-22 ES ES19877349T patent/ES2970251T3/es active Active
- 2019-10-22 ES ES23160610T patent/ES3062664T3/es active Active
- 2019-10-22 KR KR1020217015211A patent/KR102856407B1/ko active Active
- 2019-10-22 EP EP19877349.1A patent/EP3870174B1/en active Active
- 2019-10-22 WO PCT/US2019/057406 patent/WO2020086555A1/en not_active Ceased
- 2019-10-22 EA EA202190974A patent/EA202190974A1/ru unknown
- 2019-10-22 SG SG11202104117WA patent/SG11202104117WA/en unknown
- 2019-10-22 MY MYPI2021002213A patent/MY207622A/en unknown
- 2019-10-22 IL IL320867A patent/IL320867A/en unknown
- 2019-10-22 EP EP23160303.6A patent/EP4234560A3/en not_active Withdrawn
- 2019-10-22 BR BR112021007622-0A patent/BR112021007622A2/pt unknown
-
2021
- 2021-03-22 US US17/301,030 patent/US11154557B2/en active Active
- 2021-04-22 PH PH12021550905A patent/PH12021550905A1/en unknown
- 2021-04-22 SA SA521421845A patent/SA521421845B1/ar unknown
- 2021-04-22 MX MX2023012166A patent/MX2023012166A/es unknown
- 2021-04-28 ZA ZA2021/02846A patent/ZA202102846B/en unknown
- 2021-05-24 US US17/303,228 patent/US11166957B2/en active Active
- 2021-05-24 US US17/303,229 patent/US11311547B2/en active Active
-
2022
- 2022-03-18 US US17/655,483 patent/US12168013B2/en active Active
-
2024
- 2024-04-22 ZA ZA2024/03101A patent/ZA202403101B/en unknown
- 2024-08-22 AU AU2024213169A patent/AU2024213169B2/en active Active
- 2024-12-09 US US18/973,233 patent/US20250099477A1/en active Pending